Request for regulatory guidance for cancer cachexia intervention trials.

Thumbnail Image
View / Download70.27 KB

Date

2015-12

Authors

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

124
views
123
downloads

Citation Stats

Abstract

Type

Journal article

Department

Description

Provenance

Subjects

Citation

Permalink

https://hdl.handle.net/10161/13028

Published Version (Please cite this version)

10.1002/jcsm.12083

Publication Info

Fearon, Kch, JM Argiles, VE Baracos, R Bernabei, Ajs Coats, J Crawford, NE Deutz, W Doehner, et al. (2015). Request for regulatory guidance for cancer cachexia intervention trials. J Cachexia Sarcopenia Muscle, 6(4). pp. 272–274. 10.1002/jcsm.12083 Retrieved from https://hdl.handle.net/10161/13028.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Collections

Scholarly Articles
Full item page

Scholars@Duke

Crawford

Jeffrey Crawford

George Barth Geller Distinguished Professor for Research in Cancer
  1. Lung cancer/new treatment approaches.
    2. Clinical trials of hematopoietic growth factors, biological agents and targeted drug development.
    3. Cancer in the elderly and supportive care

    Accomplishments

    1. Lead Investigator of the U. S. multicenter, randomized trial of Filgrastim (G-CSF, Neupogen) to reduce the morbidity of chemotherapy-related neutropenia, leading to FDA approval 2/91.
    2. Lead Investigator of the U. S. multicenter, randomized trial of Vinorelbine (Navelbine) in treatment of patients with advanced non small cell carcinoma of lung (NSCLC), leading to FDA approval 12/94.
    3. Principal Investigator in initial phase I clinical trials of stem cell factor (SCF), megakaryocyte growth and development factor (MGDF), pegylated granulocyte-colony-stimulating factor and other novel hematopoietic growth factors.

William Joseph Evans

Adjunct Professor in the Department of Medicine

Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.